Bluejay Diagnostics, Inc. (BJDX) vs Clearmind Medicine Inc. (CMND)

A side-by-side comparison of Bluejay Diagnostics, Inc. and Clearmind Medicine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bluejay Diagnostics, Inc. logo
BJDX
Bluejay Diagnostics, Inc.
$848569
$0.82HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Clearmind Medicine Inc. logo
CMND
Clearmind Medicine Inc.
$1M
$5.76HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT

Total return — BJDX vs CMND

growth of $100 · dividends reinvested · last 4y
BJDX -100.0% (-92.4%/yr)CMND -100.0% (-94.3%/yr)BJDX compounded faster over this window
050100Start $1002023202420252026$0$0
BJDX CMND

BJDX vs CMND: by the numbers

  • •CMND is the larger company ($1M vs $848569 market cap).

Metrics side by side

Valuation

MetricBJDXCMND
P/B ratio0.090.08

Profitability

MetricBJDXCMND
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-77.23%-57.87%
ROIC-77.55%-60.41%

Go deeper

Full BJDX analysisFull CMND analysisInteractive comparison tool

Dig into the metrics

Bluejay Diagnostics ROEClearmind Medicine ROEBluejay Diagnostics operating marginClearmind Medicine operating marginBluejay Diagnostics revenue growthClearmind Medicine revenue growthBluejay Diagnostics free cash flowClearmind Medicine free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.